PARD 2021 Program
Anterior Segment
Saturday, 10 July 2021
Eastern/Miami time zone
9:00-9:05 | Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico) Welcome |
Moderators: | Erick Hernandez Bogantes (Costa Rica), Julio Hernandez Camarena (Mexico), Gerardo Graue Moreno (Mexico) |
9:05-9:10 | Alejandro Navas (Mexico) Subconjunctival sirolimus-loaded liposomes for the treatment of moderate to severe dry eye disease |
9:10-9:15 | Caberry Yu (Canada) Pain control for corneal abrasions: a meta-analysis of six topical interventions |
9:15-9:20 | Shayan Shokoohi (Canada) Effect of bevacizumab on the viability and metabolism of human corneal cells |
9:20-9:25 | Nikolaos Katsinas (Spain) Olive pomace phenolic compounds can inhibit inflammatory and oxidative–related diseases of human ocular surface epithelium |
9:25-9:30 | Po Hsiang (Shawn) Yuan (Canada) Retrospective large-cohort evaluation of trans-epithelial phototherapeutic keratectomy (PTK) for recurrent corneal erosion syndrome (RCES) |
9:30-9:35 | Roberto González-Salinas (Mexico) Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study |
9:35-9:40 | Salvador Garza (Mexico) Evaluation of meibography scores as age increases in Hispanic patients |
9:40-9:45 | Ahmed Amayem (Canada) A Non-Contact Corneal Aesthesiometer (NCCA) Validation Study in Normal Eyes |
9:45-9:50 | Mhamed Ouzzani (Algeria) Stability of Corneal Topographic Changes After Long-Term Orthokeratology |
9:50-9:55 | Rossen Hazarbassanov (Brazil) Evaluation of keratoconus detection from elevation, topography and pachymetry raw data using machine learning |
9:55-10:00 | Ricardo Soares (Portugal) Topical Insulin- Utility and results in refractory Neurotrophic Keratopathy in stages 2 and 3 |
10:00-10:05 | Isaac Vidal Paredes (Mexico) Evaluation of pirfenidone and pirfenidone-loaded liposomes for treating chemical corneal injury |
10:05-10:10 | Matthew Fung (Canada) Development of a Novel Bioartificial Surgical Outflow Tract Model for Rapid Screening of Anti-Fibrotics Adjuvants |
10:10-10:15 | Simran Mangwani Mordani (Mexico) Short-Term Effects on Corneal Endothelial Cell Density and Morphology After Deep Small Incision Lenticule Extraction (SMILE) |
10:15-10:20 | Alicia Goyeneche (Canada) Deleterious genotoxic, metabolic, and oxidative stress effects of sunlight exposure on keratinocytes and fibroblasts |
10:20-10:25 | Judith Zavala (Mexico) Restoration of corneal clarity after transplantation of an engineered corneal endothelium: preliminary in vivo model (presentation by Salvador Garza) |
10:25-10:30 | Luis Rodríguez (Mexico) Accelerated corneal cross-linking in pediatric patients with keratoconus from the northeast of Mexico: A 3-year follow-up |
10:30-10:35 | Renato Leca (Brazil) Study of the corneal temperature variation during photo-refractive procedures |
10:35-10:40 | María Pinazo-Durán (Spain) Characterization of dolphin tear metabolomics |
10:40-10:45 | Ignacio Rodríguez-Una (Spain) Early lensectomy in patients with pseudoexfoliation: long-term outcomes of effectiveness and safety |
10:45-10:50 | Miguel Hernández-Delgado (Mexico) Patient profile and outcomes regarding intraocular lens type selection in presbyopic hispanic population |
10:50-10:55 | Anna Paula Nassaralla (Brazil) Impact of visual changes on falls and postural control in patients diagnosed with senil cataract in Anápolis, Goiás, Brazil |
10:55-11:00 | Georges Nassrallah (Canada) Objective Analysis of Capsulorhexis factors and Posterior Capsular Opacification in 246 Post-Mortem Eyes |
11:00-11:05 | José A Villa-Carpes (Spain) Visual Acuity Changes with Time Following Vision through Bangerter Filters |
11:05-11:10 | Andrew Smith () The cost, components and affordability of eye examinations in optometry practices in Western Nova Scotia, Canada. |
11:10-11:15 | Denise Loya (Mexico) Scleral lenses for the management of corneal irregularities. Visual and aberrometric outcomes in Mexico. |
11:15-11:20 | Rémy Marcotte-Collard (Canada) The Effect of Optic Zone Diameter on Choroidal Response Using Bifocal Soft Multifocal Contact Lenses |
11:20-11:25 | Adnan Alawami (Canada) Visual Outcomes and Complications of Corneal Transplant With and Without Previous Glaucoma Surgery |
11:25-11:30 | Dominique Geoffrion (Canada) Tear film cytokine profiles of Boston keratoprosthesis patients with and without glaucoma |
11:30-11:35 | José A. Fernández-Albarral (Spain) Changes in cytokine and growth factor levels at different time points after experimental glaucoma induction. |
11:35-11:40 | Perrine Tami (Canada) Factors Influencing Follow-up Appointment Delays in Glaucoma Practices |
11:40-11:45 | Mónica Melo (Brazil) Association of ABCA1 rs2472493 and GAS7 rs9913911 variants with POAG in a Brazilian population |
11:45-11:50 | María del Mar Schilt-Catafal (Spain) Quantitative analysis of the three macular capillary plexuses in Open-Angle Glaucoma and Ocular Hypertension using optical coherence tomography angiography (OCTA) |
11:50-11:55 | Faisal Jarrar (Canada) Optic Disc Photography vs. Optical Coherence Tomography (OCT) in Detection of Glaucoma Progression |
11:55-12:00 | Emiliano Terán (Mexico) Machine-Learning Predictor of Refractive Error from Foveal Pit Characteristics |
12:00-12:05 | Irving Domínguez Varela (Mexico) Ophthalmological care during COVID-19 times. Perspectives from a Mexican eye healthcare system |
12:05-12:10 | Gustavo Gameiro (Brazil) Orbicularis Oculi Muscle morphometry alterations in Hemifacial Spasm |
12:10-12:15 | Hiroaki Ito (Canada) Histopathological and immunohistochemical study of metastatic orbital tumors |
12:15-12:20 | Arjan Dhoot (Canada) Factors Affecting the Time to Publication in Ophthalmology Journals: A Comprehensive Bibliometric Analysis |
12:20-12:23 | Arturo Ramirez Miranda (Mexico) Introduction of Keynote speaker Dr. Anthony Aldave |
12:23-12:35 | Anthony Aldave (USA) Keynote: COVID and the Cornea: from Controversy to Consensus |
12:35-12:40 | Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico) Q&A / End program / reminder for 17 July Posterior program |
Posterior Segment
Saturday, 17 July 2021
Eastern/Miami time zone
9:00-9:05 | Lihteh Wu (Costa Rica) & Arturo Ramirez Miranda (Mexico) Welcome |
9:05-9:08 | Lihteh Wu (Costa Rica) Introduction of Keynote speaker Dr. R.V. Paul Chan |
9:08-9:15 | R.V. Paul Chan (USA) Keynote lecture: Innovations in ROP Management: The PAAO and Global Collaborations |
9:15-9:20 | Lihteh Wu (Costa Rica) Q&A / Intro regular Program |
Moderators | Claudia Acosta (Colombia), Francisco J. Rodriguez (Colombia), Jose A. Roca (Peru) |
9:20-9:25 | Cody Lo (Canada) Risk of Requiring Glaucoma Surgery following Intravitreal anti-VEGF Injections: A Case-Control Study |
9:25-9:30 | David Sousa (Portugal) Retinal vascular reactivity in type 1 diabetes patients without retinopathy using optical coherence tomography angiography |
9:30-9:35 | Anastasiya Vinokurtseva (Canada) Treatment of ocular inflammation: effects of COX-2 acetylating immuno-resolvents (CAIRs) in THP-1-derived macrophages and a rat model of endotoxin-induced uveitis |
9:35-9:40 | Bruno Ferreira (Brazil) Assessment of Parafoveal Retinal Vasculature in Behçet’s Syndrome using Optical Coherence Tomography Angiography |
9:40-9:45 | Joana Mesquita (Portugal) Comparison of Vascular Endothelial Growth Factors (VEGFs) A and B with diabetic retinopathy severity and diabetic macular edema. Correlation between growth factors and anatomical parameters |
9:45-9:50 | Christos Boutopoulos (Canada) A smart vitrector equipped by a fiber-based OCT sensor mitigates simulated iatrogenic retinal injuries during vitrectomy in pigs |
9:50-9:55 | María Madeira (Portugal) Retinal neurodegeneration in type 2 diabetic individuals with mild retinopathy is independent of retinopathy severity progression: a 5-year longitudinal study |
9:55-10:00 | María Esther Santos Blanco (Spain) Retiprogram: A Clinical Decision Support System for Diabetic Retinopathy with Predictive Value |
10:00-10:05 | Anne Xuan-Lan Nguyen (Canada) Correlating retinal blood vessel movements with other clinical signs in progressing retinal degenerations. |
10:05-10:10 | Manlong Xu (Canada) How do RA and SLE patients differ while on long-term hydroxychloroquine therapy? |
10:10-10:15 | Myopic choroidal neovascularization: prognostic factors with a PRN regimen of Anti-VEGF therapy |
10:15-10:20 | Armin Farahvash (Canada) Understanding the Mechanism of Retinal Displacement Following Surgical Management of Rhegmatogenous Retinal Detachment: A Computer Simulation Model |
10:20-10:25 | Ojas Srivastava (Canada) Anti-VEGF switch therapy from bevacizumab to aflibercept in radiation retinopathy secondary to uveal melanoma |
10:25-10:30 | Ivan Fernandez-Bueno (Spain) Retinal cells death rates in in vitro neuroretinal degeneration model: preliminary data |
10:30-10:35 | Supriya Arora (Bahamas) One year outcome and predictors of treatment outcome in central serous chorioretinopathy (CSCR): multimodal imaging based analysis |
10:35-10:40 | Simrat Sodhi (United Kingdom) Utilisation of Machine Learning to quantify fluid volume of wet age-related macular degeneration (wARMD) patients based on swept-source optical coherence tomography (SS-OCT) imaging: The ONTARIO Study |
10:40-10:45 | Tomás Loureiro (Portugal) Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: A 24-Months Follow-up Study |
10:45-10:50 | João Leite (Portugal) Optical coherence tomography biomarkers as prognostic factors in diabetic macular edema treatment with ranibizumab – vitrectomized versus non-vitrectomized eyes |
10:50-10:55 | Timothy Yu (Canada) Collaborative Diabetic Retinopathy Severity Classification of Optical Coherence Tomography Data through Federated Learning |
10:55-11:00 | Paula Subirada Caldarone (Argentina) The neurotrophin receptor p75NTR as a new player in the development of choroidal neovascularization |
11:00-11:05 | Membrane affinity of different segments of lecithin retinol acyltransferase |
11:05-11:10 | Kenzo Tomishige (Brazil) Comparison of depressive symptoms between age-related macular degeneration and glaucoma patients who live in a developing country. |
11:10-11:15 | Natalia Binczyk (Canada) Frequency of anti-VEGF intravitreal injections (IVI) after post-injection endophthalmitis in patients with neovascular age related macular degeneration (nvD) |
11:15-11:20 | Deborah Villafranca-Baughman (Canada) Glia-derived S100ß promotes pericyte-mediated capillary constriction and reduced blood flow in glaucomatous and ischemic retinas |
11:20-11:25 | Inés López Cuenca (Spain) Assessment of macular thickness changes by OCT in asymptomatic relatives of Alzheimer’s disease patients |
11:25-11:30 | Sabiha Hacibekiroglu (Canada) Safe and immune-tolerant ‘designer’ RPE cells towards the treatment of age-related macular degeneration |
11:30-11:35 | Inés Marques (Portugal) Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study |
11:35-11:40 | Mariana da Palma (Brazil) Phenotypic and genotypic spectrum of HGSNAT-related retinopathy |
11:40-11:45 | Elena Salobrar-García (Spain) Choroidal changes as a biomarker of cerebral amyloid angiopathy in mild Alzheimer’s disease patients. |
11:45-11:50 | Bonnie He (Canada) Outcomes of scleral buckle after failed pneumatic retinopexy |
11:50-11:55 | Daniela Santos (Portugal) ACE2-overexpression protects RPE cells from inflammation and oxidative stress |
11:55-12:00 | Diogo Bitoque (Portugal) PAEMA nonviral vectors display enhanced gene transfer ability in retinal cells |
12:00-12:05 | Mohamed Abdouh (Canada) Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells |
12:05-12:10 | Christina Mastromonaco (Canada) Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: a Histopathological Study |
12:10-12:15 | Arthur Nassaralla (Brazil) Predominantely hemorragic lesion in nD and response to Anti-VEGF treatment |
12:15-12:20 | Prisca Bustamante (Canada) Potential mechanism of action of Mifepristone as antitumor treatment in Uveal melanoma |
12:20-12:25 | Kelly Coutant (Canada) Impact of melanomic extracellular vesicles in the metastatic process of uveal melanoma |
12:25-12:30 | Anna Camos-Carreras (Spain) Functional tests and ganglion cell complex measured with optical coherence tomography in Autosomal Dominant Optic Atrophy. |
12:30-12:35 | Sabrina Bergeron (Canada) Optical biopsies of peri-ocular skin cancers: how OCT imaging can heighten accessibility to specialized healthcare by telemedicine. |
12:35-12:40 | Gustavo Ortiz-Morales (Mexico) CyberKnife Robot-Assisted Radiosurgery for Ciliochoroidal Melanoma: Early Results in Mexico. |